A Study of Transcutaneous Electrical Stimulation As a Noxious Stimulus for the Glasgow Coma Scale

Part of paid clinical trials in Phoenix, Arizona.

Sponsor
Markey Olson
Study ID
NCT06681779
Status
Enrolling By Invitation

Conditions

  • Comatose

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Transcutaneous electrical stimulation — DEVICE
    Transcutaneous electrical stimulation will be used to create noxious stimuli for the GCS exam
  • Standard of Care (SOC) — OTHER
    Physical pain stimulation, as used in traditional standard care, will be used to score the GCS exam, and the device results will be compared to this SOC exam.

Study Details

The purpose of this study is to determine whether electrical stimulation can be used to replace physical stimulation to test awareness of patients with impaired consciousness. Physical stimulation can cause bruising, damaged nails and ribs, and other damage with repeated testing, and electrical stimulation may be safer and cause less distress with time. This device has not been approved by the U.S. Food and Drug Administration (FDA).

Key Dates

Start date
Oct 31, 2024
Status verified
Nov 2024
Primary completion
Dec 31, 2025
Completion
Dec 31, 2025

Study Design

Enrollment
90 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
DIAGNOSTIC

Arms

  • Experimental: E2
    Patients with a stable GCS subscore of E2, eyes opening to pain
  • Experimental: E1
    Patients with a stable GCS subscore of E2, eyes non-responsive to pain
  • Experimental: Upper Extremity M5
    Patients with a stable GCS subscore of M5, localizing, in at least one upper limb
  • Experimental: Upper Extremity M4
    Patients with a stable GCS subscore of M4, withdrawing, in at least one upper limb
  • Experimental: Upper Extremity M3
    Patients with a stable GCS subscore of M3, flexing, in at least one upper limb
  • Experimental: Upper Extremity M2
    Patients with a stable GCS subscore of M2, extending, in at least one upper limb
  • Experimental: Upper Extremity M1
    Patients with a stable GCS subscore of M1, no response to stimuli, in at least one upper limb
  • Experimental: Lower Extremity M4
    Patients with a stable GCS subscore of M4, withdrawing, in at least one lower limb
  • Experimental: Lower Extremity M3
    Patients with a stable GCS subscore of M3, flexing, in at least one lower limb
  • Experimental: Lower Extremity M1
    Patients with a stable GCS subscore of M1, no response, in at least one lower limb

Primary Outcome Measure

Comparison of Transcutaneous Stimulation Glascow Coma Scale (Exams) score with traditional SOC [ Time Frame: Less than 24 hours ]

Locations (1)

FacilityCityStateZIPSite coordinators
Barrow Neurological InstitutePhoenixArizona85013-

Find similar trials in Phoenix, AZ

Related Studies